FPT-EUROPE
18.8.2021 08:32:11 CEST | Business Wire | Press release
FPT Europe, a subsidiary of the global technology services provider FPT Corporation, has announced the collaboration with innogy Czech, a leading energy company providing natural gas, electricity and heating solutions, as well as clean mobility solutions, to migrate the innogy Czech’s entire SAP R/3-based ERP infrastructure to the SaaS cloud. As the general contractor of the project, FPT will support the customer to migrate the current system to SAP S/4HANA as part of the greenfield approach. The goal is thus a complete redesign of the Enterprise Resource Planning (ERP), which is business-critical for innogy Czech, including streamlining and simplifying all processes automated in the system. FPT is responsible for the entire scope of the project, from consulting to planning and implementation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210817005685/en/
"We entrusted FPT with the upgrade of our SAP system to S/4 HANA because of the company’s expertise, technical capabilities and years of experience in the industry," says Miloš Dušek, Senior Manager of Corporate Applications at innogy Ceska republika. "The project is of great strategic importance for innogy. FPT has proven to be a reliable strategic partner for us and has put together a qualified team to ensure that the first part of the project will be delivered successfully by the end of 2021."
Lighthouse project in the growing market of SAP S/4HANA
The aim of the project is to replace the current SAP ERP system used by innogy Czech in version R/3 ERP Central Component 6.0 EhP 8, which has so far been based on HANA DB2, with S/4HANA Private Cloud Edition. "SAP made an announcement that the company will end the support for its on-premises solutions by 2027. Many companies therefore would want to migrate their system to S/4 HANA in a timely manner," explains Andy Do, Deputy Director/Head of Delivery at FPT Europe. "FPT has strong expertise and many years of experience in cloud migration as well as SAP migration projects, but the project with innogy Czech can be considered as one of the largest end-to-end S/4HANA migration projects for us. It offers FPT a great opportunity to position ourselves as a trusted partner in the field of SAP S/4HANA migration."
The scope of work mentioned above will be applied for 5 companies within innogy Czech Republic group, including innogy Ceska republika a.s., innogy Zakaznicke sluzby, s.r.o., innogy Energie, s.r.o., innogy Energo, s.r.o. and innogy Energetika Plhov-Nachod, s.r.o.
FPT has more than 20 years of experience in providing services related to SAP. With a pool of more than 300 functional and 250 technical consultants, FPT has successfully implemented and rolled out SAP systems for customers in Southeast Asia, Japan and Europe. With SAP S/4HANA, FPT offers a wide range of services such as development, implementation and rollout. FPT also offers its own solutions in the field of Application Managed Services (AMS). FPT’s services in the areas of SAP migration, SAP customization, SAP rollout and SAP Automation Testing help its customers assure smooth and efficient implementation of SAP S/4HANA.
About FPT Europe
FPT Europe, based in Essen, Germany is a part of FPT Corporation - a technology and IT services provider headquartered in Vietnam with nearly US$2 billion in revenue and 36,000 employees. Being a pioneer in digital transformation, the company delivers world-class services in Smart factory, Digital platforms, RPA, AI, IoT, Data Analytics, Mobility, Cloud, Managed Services, Testing. FPT Software has served over 700 customers worldwide, 100 of which are Fortune 500 companies in the industries of Aerospace & Aviation, Automotive, Banking and Finance, Communications, Media and Services, Logistics & Transportation, Utilities, Consumer Packaged Goods, Healthcare, Manufacturing, Public sector, Technology and so on. Established in 2012, FPT Europe has become technology partners of 50 leading companies including Siemens, RWE, Allianz, Schaeffler, Airbus, Carlsberg and many more. For other information, please visit: www.fpt-europe.de
About innogy Czech
innogy Česká republika is a leading energy company in the Czech Republic owned by the largest Hungarian energy group MVM. innogy supplies 1.6 million customers with energy and energy-related innovative services. First class customer service is provided by own call centres and a chain of customer service centres. In addition to gas and electricity supplies, innogy produces heat and electricity in heating plants across the country with an annual heat production of 900,000 GJ. Aside from the core business, innogy focuses on clean mobility, photovoltaics and energy management services. With a nationwide network of 60+ filling stations, own CNG technology production and more than 10 million kg CNG sold annually, innogy is a strong market leader. innogy is also building up a solid position in the fast-growing solar power plants market. The company employs 1,500 highly skilled people and the innogy brand is known to more than 90% of the Czech population.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005685/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom